Magnetoliposomes in controlled-release drug delivery systems

被引:13
作者
Tomitaka A. [1 ]
Takemura Y. [2 ]
Huang Z. [3 ]
Roy U. [4 ]
Nair M. [1 ]
机构
[1] Department of Immunology and Nano-Medicine, Institute of NeuroImmune Pharmacology, Centre for Personalized Nanomedicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL
[2] Department of Electrical and Computer Engineering, Yokohama National University, Yokohama
[3] Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL
[4] Department of Health and Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX
基金
美国国家卫生研究院;
关键词
Drug delivery; Liposomes; Magnetic nanoparticles; Magnetoliposomes;
D O I
10.1615/CritRevBiomedEng.2020033002
中图分类号
学科分类号
摘要
Liposomes, one of the most promising drug delivery carriers, have been extensively studied for the treatment of various diseases and have made their way to the market. Magnetic nanoparticles have been attracting great interest for diagnostic and therapeutic applications due to their unique magnetic properties. An integration of liposomes and magnetic nanoparticles gives great potential to the field of smart drug delivery systems, including magnetically guided drug delivery, image-guided drug delivery, and externally triggered controlled drug release using hyperthermia or alternating magnetic fields. In this review, we discuss the recent development of magnetoliposomes for controlled-release drug delivery systems and their potential. © 2019 by Begell House, Inc. www.begellhouse.com.
引用
收藏
页码:495 / 505
页数:10
相关论文
共 67 条
  • [1] Lu A., Schmidt W., Matoussevitch N., Bonnemann H., Spliethoff B., Tesche B., Bill E., Kiefer W., Schuth F., Na-noengineering of a magnetically separable hydrogenation catalyst, Angew Chemie., 116, pp. 4403-4406, (2004)
  • [2] Sun S., Recent advances in chemical synthesis, self-assem-bly, and applications of FePt nanoparticles, Adv Mater, 18, 4, pp. 393-403, (2006)
  • [3] Tang S.C.N., Lo I.M.C., Magnetic nanoparticles: Essential factors for sustainable environmental applications, Water Res, 47, 8, pp. 2613-2632, (2013)
  • [4] Wang Z., Qiao R., Tang N., Lu Z., Wang H., Zhang Z., Xue X., Huang Z., Zhang S., Zhang G., Li Y., Active targeting thera-nostic iron oxide nanoparticles for MRI and magnetic res-onance-guided focused ultrasound ablation of lung cancer, Biomaterials, 127, pp. 25-35, (2017)
  • [5] Huang Y., Mao K., Zhang B., Zhao Y., Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer ther-anostics, Mater Sci Eng C, 70, pp. 763-771, (2017)
  • [6] Pankhurst Q.A., Connolly J., Jones S.K., Dobson J., Applications of magnetic nanoparticles in biomedicine, J Phys D Appl Phys, 36, 13, pp. 167-181, (2003)
  • [7] Miranda M.S., Rodrigues M.T., Domingues R.M.A., Costa R.R., Paz E., Rodriguez-Abreu C., Freitas P., Almeida B.G., Carvalho M.A., Goncalves C., Ferreira C.M., Torrado E., Reis R.L., Pedrosa J., Gomes M.E., Development of inhalable superparamagnetic iron oxide nanoparticles (SPIONs) in microparticulate system for antituberculosis drug deliv-ery, Adv Healthc Mater, 7, 15, (2018)
  • [8] Tomitaka A., Ueda K., Yamada T., Takemura Y., Heat dissi-pation and magnetic properties of surface-coated Fe3O4 nanoparticles for biomedical applications, J Magn Magn Mater, 324, 21, pp. 3437-3442, (2012)
  • [9] Tong S., Quinto C.A., Zhang L., Mohindra P., Bao G., Size-dependent heating of magnetic iron oxide nanopar-ticles, ACS Nano, 11, 7, pp. 6808-6816, (2017)
  • [10] Na H.B., Song I.C., Hyeon T., Inorganic nanoparticles for MRI contrast agents, Adv Mater, 21, 21, pp. 2133-2148, (2009)